NLRP3 and mucopolysaccharidosis: A comprehensive literature review on the inflammation-driven cell pathology in MPS [7] identified two main targets for intervening in the viscous circle of inflammation in MPS, namely (i) the TLR4 receptor and cytokine/chemokine upregulation and (ii) the activation of the inflammasome NLRP3.